Organ Transplant Immunosuppressant Drugs Market Size, Share, Trends, Growth and Forecast 2025

Organ Transplant Immunosuppressant Drugs Market

Organ Transplant Immunosuppressant Drugs Market by Drug Class (Antibodies, Steroids, mTOR Inhibitor, Antiproliferative Agents and Calcineurin Inhibitors); by Transplant Type (Pancreas, Lung, Heart, Liver, Kidney and Other); by Distribution Channel (Online Pharmacies, Retail Pharmacies and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Category: Pharmaceutical Report Format : PDF Pages: 126 Report Code: ZMR-5014 Published Date: Nov-2019 Status : Published
Market Size in 2018 Market Forecast in 2025 CAGR (in %) Base Year
USD 4.51 Billion USD 5.79 Billion 3.7% 2018

Organ Transplant Immunosuppressant Drugs Market

Organ Transplant Immunosuppressant Drugs Market: Overview

 Global demand for organ transplant immunosuppressant drugs market was valued at approximately USD 4.51 billion in 2018 and is expected to generate revenue of around USD 5.79 billion by end of 2025, growing at a CAGR of around 3.7% between 2019 and 2025. 

The report covers forecasts and analyses for the organ transplant immunosuppressant drugs market on a global and regional level. The study provides historic data from 2016 along with forecasts from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the organ transplant immunosuppressant drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the organ transplant immunosuppressant drugs market on a global as well as regional level.

Global Organ Transplant Immunosuppressant Drugs Market SizeRequest Free Sample

In order to give the users of this report a comprehensive view of the organ transplant immunosuppressant drugs market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides a company market share analysis in order to give a broader overview of the key players in the organ transplant immunosuppressant drugs market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new drug class launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the organ transplant immunosuppressant drugs market on a global and regional basis.

The study provides a crucial view on organ transplant immunosuppressant drugs by segmenting the market based on drug class, Transplant Type,  and region. All the segments of the organ transplant immunosuppressant drugs market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Organ transplant refers to a medical procedure wherein a donor organ is transplanted into the body of a recipient to replace a missing or damaged organ. Autograft is a transplant type wherein organs or tissues are transplanted in the same person’s body. Allograft can be from a cadaveric or living source and refers to a transplant between two subjects of the same species. Organ transplantation is usually done no other treatment works or in case of end-state organ failures such as kidney, heart, or liver failure. The immune system may attack the newly transplanted organ if the donor and recipients are not matched. Transplant rejection is quite common and the person with a transplanted organ has to take immunosuppressant drugs for a lifetime.

The demand for the organ transplant immunosuppressant drugs market is driven by growing demand for transplantation, increasing investment in research and development in tissue engineering, and technological advancements in organ transplant. Increasing chronic disease burden is another factor that is contributing to the organ transplant immunosuppressant drugs market growth. However, the low availability of organs and high cost of overall transplantation procedures may hamper the market growth.

Global Organ Transplant Immunosuppressant Drugs Market Size: Segmentation

Based on drug class, the global organ transplant immunosuppressant drugs market is bifurcated into antibodies, steroids, mTOR inhibitors, antiproliferative agents, and calcineurin inhibitors. The calcineurin inhibitors drug class segment held the largest market share in 2018 whereas the antibodies segment is expected to exhibit the highest CAGR over the forecast period. Calcineurin inhibitors drug class includes majorly two drugs cyclosporine and tacrolimus. These effective drugs have widely been used for almost 20 years.

Based on transplant type global organ transplant immunosuppressant drugs market is bifurcated into pancreas, lung, heart, liver, kidney, and others. The kidney transplant was the most common transplant type across the globe in 2018. This is attributed to the comparatively easy availability of donor organs compared to other organs. Also, a kidney transplant is more cost-effective compared to prolonged periods of dialysis.

Based on the distribution channel global organ transplant immunosuppressant drugs market is segmented into retail pharmacies, online pharmacies, and hospital pharmacies. Hospital pharmacies held the leading market share in 2018 since it is the most widely preferred channel of distribution.

Global Lambda Cyhalothrin Market: Regional Analysis

North America represents a developed regional market for organ transplant immunosuppressant drugs. The presence of favorable reimbursement policies, the presence of developed healthcare facilities, technological advancements, and increasing healthcare spending are major factors driving the market growth in this region. Europe was the second largest market in 2018. Asia Pacific is projected to witness rapid CAGR for the organ transplant immunosuppressant drugs market. A dense population base, increasing chronic disease burden, increasing healthcare expenditure, and introduction of favorable reimbursement policies are expected to boost market growth in the Asia Pacific. Latin America is will register noticeable growth over the forecast period. The Middle East and Africa will register sluggish growth in the years to come as a result of a lack of advanced healthcare infrastructure.

Organ Transplant Immunosuppressant Drugs Market Size: Report Scope

Report Attributes Report Details
Report Name Organ Transplant Immunosuppressant Drugs Market Size Report
Market Size in 2018 USD 4.51 Billion
Market Forecast in 2025 USD 5.79 Billion
Growth Rate CAGR of 3.7%
Number of Pages 188
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Bristol-Myers Squibb Company, Veloxis Pharmaceuticals A/S, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Mylan Laboratories, Inc., Novartis AG, Accord Healthcare Ltd., Sanofi Genzyme, and Astellas Pharma, Inc. among others.
Segments Covered By Drug Class, By Transplant Type, By Distribution Channel, By End-Use And By Region.
Base Year 2018
Historical Year 2015 to 2018
Forecast Year 2018 - 2025
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Organ Transplant Immunosuppressant Drugs Market Size: Competitive Players

  • Bristol-Myers Squibb Company
  • Veloxis Pharmaceuticals A/S
  • GlaxoSmithKline plc
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Mylan Laboratories
  • Novartis AG
  • Accord Healthcare Ltd.
  • Sanofi Genzyme
  • Astellas Pharma

The report segment of the global organ transplant immunosuppressant drugs market is as follows:

Global Organ Transplant Immunosuppressant Drugs Market: By Drug Class

  • Calcineurin Inhibitors
  • Antiproliferative Agents
  • mTOR Inhibitor
  • Steroids
  • Antibodies

Global Organ Transplant Immunosuppressant Drugs Market: By Transplant Type

  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • Other

Global Organ Transplant Immunosuppressant Drugs Market: By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Organ Transplant Immunosuppressant Drugs Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of The Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Global demand for organ transplant immunosuppressant drugs market was valued at approximately USD 4.51 billion in 2018 and is expected to generate revenue of around USD 5.79 billion by end of 2025

Bristol-Myers Squibb Company, Veloxis Pharmaceuticals A/S, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Mylan Laboratories, Inc., Novartis AG, Accord Healthcare Ltd., Sanofi Genzyme, and Astellas Pharma, Inc. among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed